H.C. Wainwright analyst Ed Arce reiterated a Buy rating and $7 price target on AcelRx Pharmaceuticals (NASDAQ: ACRX) said the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

AcelRx Pharma (ACRX) Halted, News PendingOctober 12, 2018 6:55 AM AcelRx (ACRX) Briefing Docs 'Positive', Expect Favorable Vote - OppenheimerOctober 10, 2018 12:24 PM AcelRx Pharmaceuticals (ACRX) PT Raised to $10 at Ladenburg ThalmannOctober 10, 2018 9:56 AM AcelRx (ACRX) Could Have Positive AdCom Vote - Cantor FitzgeraldOctober 10, 2018 9:45 AM AcelRx Pharma (ACRX) shares on watch as FDA briefing docs releasedOctober 10, 2018 8:05 AM